ACHV Achieve Life Sciences Inc.

1.45
+0.01  (+1%)
Previous Close 1.44
Open 1.41
Price To Book 0.69
Market Cap 9745599
Shares 6,721,103
Volume 61,603
Short Ratio
Av. Daily Volume 294,111

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2b trial initiation announced October 30, 2018 with data due mid-2019.
Cytisine
Smoking cessation

Latest News

  1. Zacks.com highlights: Asbury Automotive, OncoGenex Pharmaceuticals, aTyr Pharma, Avinger and Sunesis Pharmaceuticals
  2. 5 Top-Ranked Rising P/E Stocks to Lure Investors
  3. Achieve Reports Financial Results for Third Quarter 2018 and Provides Cytisinicline (Cytisine) Clinical Development Update
  4. Achieve Life Sciences to Announce Third Quarter 2018 Financial Results and Host Conference Call and Webcast on November 7, 2018
  5. 3 Healthcare Stocks that Could Move on Industry Growth
  6. Achieve Life Sciences Announces Initiation of Phase 2b ORCA-1 Trial Evaluating Cytisinicline (cytisine) for Smoking Cessation
  7. Achieve Life Sciences Stock Will Probably Tumble Further
  8. Achieve Announces Pricing of $5.6 Million Registered Direct Offering
  9. Achieve Life Sciences' stock rockets on positive study results for smoking cessation drug
  10. Achieve Announces Results of Clinical Study Demonstrating Similar Bioavailability for a New Cytisine Formulation in Fed and Fasted Subjects
  11. Achieve to Present at the Ladenburg Thalmann 2018 Healthcare Conference on October 2, 2018
  12. Achieve Announces Positive Cytisine Data Published in International Journal of Drug Policy
  13. Achieve Life Sciences Announces Cytisine Data Presented at the Society for Research on Nicotine and Tobacco Europe (SRNT-E) Annual Conference
  14. Achieve to Present at the H.C. Wainwright 20th Annual Global Investment Conference on September 6, 2018
  15. Achieve Reports Financial Results for Second Quarter 2018 and Provides Cytisine Clinical Development Update
  16. Achieve Life Sciences to Release Second Quarter 2018 Financial Results and Host Conference Call and Webcast on August 8, 2018
  17. Today's Research Reports on Stocks to Watch: Achieve Life Sciences and Pfizer
  18. Achieve Life Sciences Shares Surge On Development Plan For Smoking Cessation Candidate
  19. Achieve Life Sciences Announces Advancement of Cytisine Development Program Following Meeting with the FDA
  20. Today’s Research Reports on Stocks to Watch: Puma Biotechnology and Achieve Life Sciences

SEC Filings

  1. EFFECT - Notice of Effectiveness 181224780
  2. S-1 - General form for registration of securities under the Securities Act of 1933 181208794
  3. S-8 - Securities to be offered to employees in employee benefit plans 181167118
  4. 10-Q - Quarterly report [Sections 13 or 15(d)] 181166810
  5. 8-K - Current report 181166595
  6. SC 13G - Statement of acquisition of beneficial ownership by individuals 181118955
  7. 8-K - Current report 181098380
  8. 424B5 - Prospectus [Rule 424(b)(5)] 181098305
  9. 8-K - Current report 181095082
  10. 8-K - Current report 181081681